NCT03761225 2023-09-29Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate CancerAB SciencePhase 3 Completed714 enrolled
NCT01732549 2019-11-22A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyIpsenPhase 2 Terminated144 enrolled 22 charts